Regina ChoiHead of sCMO (small-scale DS CMO) Business Unit at Samsung BioLogics
Regina Choi-Rivera is the new head of Samsung BioLogics’ Clinical & Small-Scale Commercial Contract Manufacturing Organization (sCMO), managing two independent small scale drug substance cGMP manufacturing facilities (2 x 1KL stainless steel facility and 2 x 1KL single use facility). Prior to this role, she led SBL’s Project Management Team, overseeing technology transfer of over 30 drugs. Under her leadership, SBL received consecutive years of CMO leadership awards in categories relating to reliability and service. She has an innate ability to de-complicate tech transfer and drug manufacturing at CMOs. With 23 years in biotech and a comprehensive knowledge of large molecule DS and DP production, she partners with drug companies to advance their drugs through commercialization.